Studies of initiation and promotion of carcinogenesis by N-nitroso compounds.
Complete carcinogens must possess both initiating and promoting properties. Most N-nitroso compounds are mutagens and are considered to be initiators, but some are not mutagenic and yet are complete carcinogens. To investigate the two activities, brief treatments of male F344 rats with each of three mutagens, nitrosodimethylurea, nitrosodiethylurea and nitrosobis-(2-oxopropyl)-amine, were followed by chronic treatment (40 weeks) with one of four non-mutagens, nitrosomethyl-3-carboxypropylamine, nitrosodiethanolamine, nitrosomethyl-2-hydroxypropylamine or phenobarbital, the last being a well-known promotor of liver tumors in rats. Each treatment group consisted of 18 animals and there were control groups of 15 animals without initiation and 15 animals without promotion. All surviving rats were sacrificed at week 78. There were almost no tumors in untreated controls or in groups treated with the promotors, other than bladder tumors in one group. Certain tumors were numerous in the initiated groups, but there were only a few instances of increased incidences after treatment with the promotors. The action of the initiators appeared to be the dominant factor and there was scant indication in this experiment of the induction of tumors by the promotors of promotion of initiated cells in most organs (e.g. the liver). This indicates that it is unlikely that non-genotoxic carcinogens induce tumors by promotion of already-initiated cells, but that some other mechanism prevails.
Hasegawa
R
R
First Department of Pathology, Nagoya City University Medical School, Nagoya, Japan.
Futakuchi
M
M
Mizoguchi
Y
Y
Yamaguchi
T
T
Shirai
T
T
Ito
N
N
Lijinsky
W
W
D000818:Animals; D002273:Carcinogens / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced; D004052:Diethylnitrosamine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005038:Ethylnitrosourea / Q000008:administration & dosage / Q000031:analogs & derivatives; D008297:Male; D008770:Methylnitrosourea / Q000008:administration & dosage / Q000031:analogs & derivatives; D009153:Mutagens / Q000008:administration & dosage*; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000401:mortality; D009602:Nitrosamines / Q000008:administration & dosage; D010634:Phenobarbital / Q000008:administration & dosage; D051381:Rats; D011916:Rats, Inbred F344; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced
D002273:Carcinogens; D009153:Mutagens; D009602:Nitrosamines; C001049:N,N'-dimethylnitrosourea; C014129:N-nitrosodiethanolamine; D004052:Diethylnitrosamine; C061090:1,3-diethyl-1-nitrosourea; C013622:nitrosobis(2-oxopropyl)amine; C044779:4-(N-nitroso-N-methylamino)butyric acid; D008770:Methylnitrosourea; C055158:N-nitrosomethyl-(3-hydroxypropyl)amine; D005038:Ethylnitrosourea; D010634:Phenobarbital